New Product Watch

Premium

CGC Genetics this week introduced a microarray panel to complement clinical diagnosis of cases where there is evidence of syndromic and nonsyndromic congenital deafness.

According to the firm, the test identifies the most frequent genetic alterations, which include 312 point mutations in 32 genes, involved in congenital hearing loss.

CGC's assay is run on the Illumina BeadXpress system.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.